. 2020 May 8;48(6):366–372. doi: 10.1016/j.mpmed.2020.03.006

Table 2.

Antiviral treatments for respiratory viruses

Virus	Treatment
Influenza	Neuraminidase inhibitors (zanamivir, oseltamivir)^a
Influenza	Amantadine
Parainfluenza	Ribavarin^b, ^c
Parainfluenza	IVIG^b
Respiratory syncytial virus	Ribavarin^c
Respiratory syncytial virus	Palivizumab
Human metapneumovirus	Ribavarin^b, ^c
Human metapneumovirus	IVIG^b
Adenovirus	Ribavarin^b, ^c
	Cidofovir^b
	Brincidofovir^d

IVIG, Intravenous immunoglobulin.

Effective at reducing disease severity and duration.

In vitro activity present but no recommendations on treatment are currently available owing to lack of data.

Can be administered orally, intravenously or nebulized.

In Phase III clinical trials.